Log in
Enquire now
‌

US Patent 7052695 Angiopoietins and methods of treating hypertension

Patent 7052695 was granted and assigned to Regeneron Pharmaceuticals on May, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Date Filed
October 18, 2002
0
Date of Patent
May 30, 2006
0
Patent Application Number
10274222
0
Patent Citations Received
‌
US Patent 12076033 Ablation device with optimized input power profile and method of using the same
0
‌
US Patent 12064420 Tie-2 activators targeting the Schlemm's canal
0
‌
US Patent 12133765 Systems and methods for real-time tracking of a target tissue using imaging before and during therapy delivery
0
‌
US Patent 12102845 Ultrasound-based neuromodulation system
0
‌
US Patent 11998266 Intravascular energy delivery
0
Patent Inventor Names
Susan Croll Kalish
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7052695
0
Patent Primary Examiner
‌
Lorraine Spector
0

Find more entities like US Patent 7052695 Angiopoietins and methods of treating hypertension

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.